168 related articles for article (PubMed ID: 36971544)
1. Genome-Scale Analysis of Cellular Restriction Factors That Inhibit Transgene Expression from Adeno-Associated Virus Vectors.
Ngo AM; Puschnik AS
J Virol; 2023 Apr; 97(4):e0194822. PubMed ID: 36971544
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Silencing of Recombinant Adeno-associated Virus Genomes by NP220 and the HUSH Complex.
Das A; Vijayan M; Walton EM; Stafford VG; Fiflis DN; Asokan A
J Virol; 2022 Feb; 96(4):e0203921. PubMed ID: 34878926
[TBL] [Abstract][Full Text] [Related]
3. Hybrid adeno-associated viral vectors utilizing transposase-mediated somatic integration for stable transgene expression in human cells.
Zhang W; Solanki M; Müther N; Ebel M; Wang J; Sun C; Izsvak Z; Ehrhardt A
PLoS One; 2013; 8(10):e76771. PubMed ID: 24116154
[TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of Small Molecules That Enhance Recombinant Adeno-associated Virus Transduction following High-Throughput Screens.
Nicolson SC; Li C; Hirsch ML; Setola V; Samulski RJ
J Virol; 2016 Aug; 90(16):7019-7031. PubMed ID: 27147738
[TBL] [Abstract][Full Text] [Related]
5. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
Hirsch ML; Wolf SJ; Samulski RJ
Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
[TBL] [Abstract][Full Text] [Related]
6. Insight into the mechanism of inhibition of adeno-associated virus by the Mre11/Rad50/Nbs1 complex.
Lentz TB; Samulski RJ
J Virol; 2015 Jan; 89(1):181-94. PubMed ID: 25320294
[TBL] [Abstract][Full Text] [Related]
7. Adeno-Associated Virus Serotype-Specific Inverted Terminal Repeat Sequence Role in Vector Transgene Expression.
Earley LF; Conatser LM; Lue VM; Dobbins AL; Li C; Hirsch ML; Samulski RJ
Hum Gene Ther; 2020 Feb; 31(3-4):151-162. PubMed ID: 31914802
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus type 1/adeno-associated virus hybrid vectors mediate site-specific integration at the adeno-associated virus preintegration site, AAVS1, on human chromosome 19.
Heister T; Heid I; Ackermann M; Fraefel C
J Virol; 2002 Jul; 76(14):7163-73. PubMed ID: 12072516
[TBL] [Abstract][Full Text] [Related]
9. AAV vectors containing rDNA homology display increased chromosomal integration and transgene persistence.
Wang Z; Lisowski L; Finegold MJ; Nakai H; Kay MA; Grompe M
Mol Ther; 2012 Oct; 20(10):1902-11. PubMed ID: 22990673
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of gene transfer with recombinant adeno-associated virus (rAAV) vectors into primary B-cell chronic lymphocytic leukemia cells by CpG-oligodeoxynucleotides.
Theiss HD; Kofler DM; Büning H; Aldenhoff AL; Kaess B; Decker T; Baumert J; Hallek M; Wendtner CM
Exp Hematol; 2003 Dec; 31(12):1223-9. PubMed ID: 14662328
[TBL] [Abstract][Full Text] [Related]
11. Genomic stability of self-complementary adeno-associated virus 2 during early stages of transduction in mouse muscle in vivo.
Ren C; Kumar S; Shaw DR; Ponnazhagan S
Hum Gene Ther; 2005 Sep; 16(9):1047-57. PubMed ID: 16149903
[TBL] [Abstract][Full Text] [Related]
12. Adeno-associated viral vector-mediated transgene expression is independent of DNA methylation in primate liver and skeletal muscle.
Léger A; Le Guiner C; Nickerson ML; McGee Im K; Ferry N; Moullier P; Snyder RO; Penaud-Budloo M
PLoS One; 2011; 6(6):e20881. PubMed ID: 21687632
[TBL] [Abstract][Full Text] [Related]
13. Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids.
Chamberlain K; Riyad JM; Weber T
Hum Gene Ther Methods; 2016 Feb; 27(1):1-12. PubMed ID: 26757051
[TBL] [Abstract][Full Text] [Related]
14. Adeno-associated viral vectors engineered for macrolide-adjustable transgene expression in mammalian cells and mice.
Fluri DA; Baba MD; Fussenegger M
BMC Biotechnol; 2007 Nov; 7():75. PubMed ID: 17986332
[TBL] [Abstract][Full Text] [Related]
15. Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors.
Manning WC; Zhou S; Bland MP; Escobedo JA; Dwarki V
Hum Gene Ther; 1998 Mar; 9(4):477-85. PubMed ID: 9525309
[TBL] [Abstract][Full Text] [Related]
16. Recombinant adeno-associated virus vectors induce functionally impaired transgene product-specific CD8+ T cells in mice.
Lin SW; Hensley SE; Tatsis N; Lasaro MO; Ertl HC
J Clin Invest; 2007 Dec; 117(12):3958-70. PubMed ID: 18008010
[TBL] [Abstract][Full Text] [Related]
17. The adeno associated viral vector as a strategy for intradiscal gene transfer in immune competent and pre-exposed rabbits.
Lattermann C; Oxner WM; Xiao X; Li J; Gilbertson LG; Robbins PD; Kang JD
Spine (Phila Pa 1976); 2005 Mar; 30(5):497-504. PubMed ID: 15738780
[TBL] [Abstract][Full Text] [Related]
18. The complex and evolving story of T cell activation to AAV vector-encoded transgene products.
Mays LE; Wilson JM
Mol Ther; 2011 Jan; 19(1):16-27. PubMed ID: 21119617
[TBL] [Abstract][Full Text] [Related]
19. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes.
Lieber A; Steinwaerder DS; Carlson CA; Kay MA
J Virol; 1999 Nov; 73(11):9314-24. PubMed ID: 10516040
[TBL] [Abstract][Full Text] [Related]
20. Correction of mutant Fanconi anemia gene by homologous recombination in human hematopoietic cells using adeno-associated virus vector.
Paiboonsukwong K; Ohbayashi F; Shiiba H; Aizawa E; Yamashita T; Mitani K
J Gene Med; 2009 Nov; 11(11):1012-9. PubMed ID: 19653252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
